Evidence map›Paper›PMID 25232709›Full record

ReviewMolecules (Basel, Switzerland)2014

1,4-naphthoquinones: from oxidative damage to cellular and inter-cellular signaling.

Lars-Oliver Klotz, Xiaoqing Hou, Claus Jacob

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Mechanism ofPlants (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Biofilm · 2025
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Reaction Mechanisms of HAntioxidants (Basel, Switzerland) · 2024
    Article
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lars-Oliver KlotzDepartment of Nutrigenomics, Institute of Nutrition, Friedrich-Schiller-University Jena, Dornburger Str. 29, 07743 Jena, Germany. lars-oliver.klotz@uni-jena.de.
Xiaoqing HouFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 2055 Katz Group Centre for Pharmacy and Health Research, 11361 87Ave, Edmonton, AB T6G 2E1, Canada.
Claus JacobDivision of Bioorganic Chemistry, School of Pharmacy, Saarland State University, Campus, Building B 2.1., Room 1.13, 66123 Saarbruecken, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Naphthoquinones may cause oxidative stress in exposed cells and, therefore, affect redox signaling. Here, contributions of redox cycling and alkylating properties of quinones (both natural and synthetic, such as plumbagin, juglone, lawsone, menadione, methoxy-naphthoquinones, and others) to cellular and inter-cellular signaling processes are discussed: (i) naphthoquinone-induced Nrf2-dependent modulation of gene expression and its potentially beneficial outcome; (ii) the modulation of receptor tyrosine kinases, such as the epidermal growth factor receptor by naphthoquinones, resulting in altered gap junctional intercellular communication. Generation of reactive oxygen species and modulation of redox signaling are properties of naphthoquinones that render them interesting leads for the development of novel compounds of potential use in various therapeutic settings.

Indexed as

Alkylating AgentsAnimalsCell CommunicationHumansNaphthoquinonesOxidation-ReductionOxidative StressProtein Processing, Post-TranslationalReceptor Protein-Tyrosine KinasesSignal Transduction1,4-naphthoquinoneAlkylating AgentsNaphthoquinonesReceptor Protein-Tyrosine Kinases

Identifiers

PMID25232709
PMCPMC6270801

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.